Clinical Trial Update: Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of isotretinoin plus dexamethasone for multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Neoplasm

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• ISOTRETINOIN (Isotretinoin)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | Status: COMPLETED